Lisa Vermij
9PUBLICATIONS
43CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Oct 07, 2024
Clinical and Molecular Characteristics of High-Risk, Recurrent, or Metastatic Endometrial Cancer That Is Human Epidermal Growth Factor Receptor 2-Low.Dione van Dijk, Lisa Vermij, Alicia León-Castillo
|Sep 29, 2023
Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas.Amy Jamieson, Lisa Vermij, Claire J H Kramer
|May 25, 2023
<i>QPOLE</i>: A Quick, Simple, and Cheap Alternative for <i>POLE</i> Sequencing in Endometrial Cancer by Multiplex Genotyping Quantitative Polymerase Chain Reaction.Anne Sophie V M Van den Heerik, Natalja T Ter Haar, Lisa Vermij
|Jan 23, 2023
Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry.Lisa Vermij, Jan J Jobsen, Alicia León-Castillo
|Jun 25, 2022
p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial.Lisa Vermij, Alicia Léon-Castillo, Naveena Singh
|Apr 09, 2021
Performance of a HER2 testing algorithm specific for p53-abnormal endometrial cancer.Lisa Vermij, Naveena Singh, Alicia Leon-Castillo
Pageof 2
Frequent Collaborators
6 joint publications
Carien L Creutzberg
5 joint publications
Nanda Horeweg
4 joint publications
Emma J Crosbie
4 joint publications
Tjalling Bosse
4 joint publications
Jan Jobsen
3 joint publications
Naveena Singh
3 joint publications
C Blake Gilks
2 joint publications
Cathelijne Post
2 joint publications
Ludy Lutgens
2 joint publications
Alexandra Leary
